Form D · Biotechnology

ARC Medical Inc.

Richmond, A1 · CIK 0001505556

Offering snapshot reported Oct 9, 2026 · SEC filing

Reported sold
$167K
Offering amount: $167K
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 24, 2026
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$83.7K$167KAug 10, 2026: $117,668.00Aug 10, 2026Oct 9, 2026: $167,388.00Oct 9, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$117,668 → $167,388
  • Reported investors2 → 3

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 9, 2026Amendment$167,388$49,720vs Aug 10, 20263SEC filing
Aug 10, 2026Initial$117,668No comparison2SEC filing
Nov 10, 2025Amendment$1,496,178$103,043vs Nov 6, 202510SEC filing
Nov 6, 2025Amendment$1,393,135$391,639vs Oct 15, 202510SEC filing
Oct 15, 2025Amendment$1,001,496$100,000vs Aug 7, 202510SEC filing
Aug 7, 2025Amendment$901,496No comparison9SEC filing
May 20, 2025Amendment$824,994$184,638vs Apr 29, 20259SEC filing
Apr 29, 2025Amendment$640,356$336,892vs Oct 18, 20248SEC filing
Mar 21, 2025Amendment$589,064$285,600vs Oct 18, 20248SEC filing
Nov 15, 2024Amendment$509,018$205,554vs Oct 18, 20248SEC filing
Oct 18, 2024Initial$303,464No comparison6SEC filing
Jun 25, 2024Amendment$650,000$75,000vs Apr 17, 20243SEC filing
Apr 17, 2024Amendment$575,000$100,000vs Feb 14, 20243SEC filing
Feb 14, 2024Amendment$475,000$75,000vs Dec 28, 20232SEC filing
Dec 28, 2023Amendment$400,000$200,000vs Sep 18, 20232SEC filing
Sep 18, 2023Initial$200,000No comparison1SEC filing
May 16, 2022Amendment$677,754$477,754vs Dec 23, 20216SEC filing
Mar 1, 2022Amendment$525,772$124,882vs Jan 10, 20225SEC filing
Jan 10, 2022Amendment$400,890$200,890vs Dec 23, 20213SEC filing
Dec 23, 2021Initial$200,000No comparison1SEC filing
Mar 10, 2021Amendment$750,000$200,000vs Jan 19, 20219SEC filing
Jan 19, 2021Initial$550,000No comparison7SEC filing
Apr 10, 2015Amendment$60,000$35,000vs Mar 12, 20152SEC filing
Mar 12, 2015Initial$25,000No comparison1SEC filing
Sep 29, 2014Initial$100,000No comparison1SEC filing
Dec 19, 2013Initial$25,000No comparison1SEC filing
Mar 6, 2013Initial$92,688No comparison2SEC filing
Jan 3, 2013Initial$47,857No comparison2SEC filing
Apr 5, 2011Initial$250,001No comparison4SEC filing
Dec 22, 2010Initial$99,010No comparison1SEC filing
Nov 16, 2010Initial$127,397No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-593621
C$1.4093=US$1.00

Source: Form D, filed Oct 9, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Bruce Hay Director
Lai (Alex) Huynh Director, Executive
Lai Huynh Executive
Deng Mao Director
Richard Simons Director
Christopher Springate Director, Executive
Pamela Teetaert Executive
Ang Zhao Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
#8 3071 No. 5 Road
Richmond, A1, V6X 2T4
Phone: (604) 222-9577